Live from the NIH registry
Studies recruiting near San Bernardino right now
Top 25 of 478 recruiting studies, sorted by proximity — each links to its official registry page
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
WRAP North America
Venous Stenosis, Venous Occlusion
N/A
Observational 250 participants sought
Apex Research of Riverside — Riverside, California (14.3 mi)
· Sponsor: Merit Medical Systems, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic Impairment
Hepatic Impairment
Phase 1
Interventional 30 participants sought
USA003 — San Dimas, California (29.4 mi)
· Sponsor: Insmed Incorporated
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Spinal Muscular Atrophy (SMA)
N/A
Observational 700 participants sought
Loma Linda University Health — Loma Linda, California (6.7 mi)
· Sponsor: Novartis Pharmaceuticals
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Oropharyngeal Cancer
Phase 3
Interventional 510 participants sought
City of Hope Corona — Corona, California (24.1 mi)
· Sponsor: Canadian Cancer Trials Group
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
Kaiser Permanente Fontana Medical Center — Fontana, California (8.7 mi)
· Sponsor: Pfizer
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
Inland Empire Clinical Trials — Rialto, California (5.0 mi)
· Sponsor: Regeneron Pharmaceuticals
A Physiologic Comparison of Two Approaches to Treating Peripheral Neuropathy
Peripheral Neuropathy With Type 2 Diabetes
N/A
Interventional 40 participants sought
Loma Linda University Health Neuropathic Therapy Center — Loma Linda, California (6.7 mi)
· Sponsor: Loma Linda University
Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial
Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm
N/A
Interventional 216 participants sought
City of Hope Upland — Upland, California (20.5 mi)
· Sponsor: City of Hope Medical Center
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
Major Depressive Disorder (MDD), Major Depressive Disorder With Anxious Distress
Phase 2
Interventional 360 participants sought
Seaport Investigator Site — Redlands, California (8.7 mi)
· Sponsor: Seaport Therapeutics
A Study to Assess How Effective and Safe NVD003 is for Treating Patients With Congenital Pseudarthrosis of the Tibia.
Congenital Pseudarthrosis of Tibia
Phase 3
Interventional 12 participants sought
Loma Linda University Health — Loma Linda, California (6.7 mi)
· Sponsor: Novadip Biosciences
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Biochemically Recurrent Prostate Carcinoma, Metastatic Prostate Carcinoma
Phase 3
Interventional 804 participants sought
City of Hope Upland — Upland, California (20.5 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Secukinumab Open Label Roll-over Extension Protocol
Autoimmunity, Inflammation
Phase 4
Interventional 1,000 participants sought
Inland Rheumatology Clinical Trials INC — Upland, California (20.5 mi)
· Sponsor: Novartis Pharmaceuticals
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Upland, California (20.5 mi)
· Sponsor: Alkermes, Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: National Cancer Institute (NCI)
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
Kaiser Permanente-Fontana — Fontana, California (8.7 mi)
· Sponsor: NRG Oncology
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).
Juvenile Psoriatic Arthritis
Phase 1
Interventional 20 participants sought
Loma Linda University Health — Loma Linda, California (6.7 mi)
· Sponsor: Novartis Pharmaceuticals
Efficacy, Safety, and Tolerability of NBI-1065890 Versus Placebo in Adults With Tardive Dyskinesia
Tardive Dyskinesia
Phase 2
Interventional 100 participants sought
Neurocrine Clinical Site — Chino, California (24.3 mi)
· Sponsor: Neurocrine Biosciences
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
Kaiser Permanente-Fontana — Fontana, California (8.7 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Kaiser Permanente-Riverside — Riverside, California (14.3 mi)
· Sponsor: NRG Oncology
Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Phase 2
Interventional 29 participants sought
City of Hope at Upland — Upland, California (20.5 mi)
· Sponsor: City of Hope Medical Center
Building Resilient Families
Adverse Childhood Experiences
N/A
Interventional 340 participants sought
Loma Linda University — Loma Linda, California (6.7 mi)
· Sponsor: Loma Linda University
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Clinical Innovations, Inc. dba CITrials — Riverside, California (14.3 mi)
· Sponsor: Bristol-Myers Squibb
Proton Therapy in the Treatment of Liver Metastases
Liver Metastases
N/A
Interventional 35 participants sought
Loma Linda University Medical Center — Loma Linda, California (6.7 mi)
· Sponsor: Loma Linda University